Utah Admin. Code R66-10-9 - Inventory

(1) A closed-door medical cannabis pharmacy shall inventory and store medical cannabis products and medical cannabis devices:

(a) in a manner to permit clear identification, separation, and easy retrieval of a product; and

(b) in an environment necessary to maintain the integrity of product inventory.

(2) A closed-door medical cannabis pharmacy shall use the Inventory Control System (ICS) to establish a record of each transaction, sale, return, and disposal.

(3) A closed-door medical cannabis pharmacy shall input information regarding the purchase of medical cannabis products or medical cannabis devices into the ICS immediately following each transaction.

(4) A closed-door medical cannabis pharmacy shall :

(a) establish and document inventory controls of medical cannabis product and medical cannabis devices to help the pharmacy detect any diversion, theft, or loss of product in a timely manner;

(b) record inventory findings;

(c) keep records for five years; and

(d) make records available for inspection by the department.

(5)

(a) A PMP at each closed-door medical cannabis pharmacy shall conduct an inventory audit that includes a reconciliation of each medical cannabis product and medical cannabis device stored at the closed-door pharmacy with the pharmacy's inventory record in the ICS.

(b) Pharmacy agents may assist a PMP with the inventory.

(c) An inventory audit shall include:

(i) the time and date of completing the inventory;

(ii) a summary of the inventory findings; and

(iii) the name and signature or initials of the PMP who conducted the inventory.

(6) If a closed-door medical cannabis pharmacy employee identifies a reduction in the number of medical cannabis products or medical cannabis devices in their inventory that is not due to a documented cause, the pharmacy shall immediately:

(a) determine where the loss occurred and take and document corrective action;

(b) inform the department of the loss; and

(c) provide the corrective action taken within two business days after the discovery of the loss.

(7) If a reduction in the number of medical cannabis products or medical cannabis devices in the inventory is due to actual or suspected criminal activity, the closed-door medical cannabis pharmacy shall immediately make a written report identifying the circumstances surrounding the reduction to:

(a) the department; and

(b) to law enforcement with jurisdiction where the criminal acts occurred.

(8) If a closed-door medical cannabis pharmacy employee identifies an increase in the amount of medical cannabis products or medical cannabis devices in the inventory not due to documented causes, the closed-door pharmacy shall determine where the increase occurred and take and document corrective action.

(9)

(a) The PIC shall conduct and complete an annual comprehensive inventory of products at a closed-door medical cannabis pharmacy within 72 hours or three working days of the closed-door pharmacy's first annual comprehensive inventory.

(b) The annual comprehensive inventory shall include:

(i) the time and date of the inventory;

(ii) a summary of the inventory findings; and

(iii) the name and signature or initials of the PIC who conducted the inventory.

(10) The closed-door medical cannabis pharmacy shall keep records of each inventory audit and comprehensive annual inventory for five years.

(11)

(a) Inventory records may be electronic or physical.

(b) If physical records are kept, the physical records shall be located at the closed-door medical cannabis pharmacy where the medical cannabis products and medical cannabis devices are located.

(c) If a closed-door medical cannabis pharmacy intends to maintain records at a location other than the closed-door pharmacy, they may send a written request to the department that contains:

(i) the closed-door medical cannabis pharmacy name and license number; and

(ii) the name and address of the alternate location.

(d) The department shall approve or deny the request through written notification.

(e) A copy of the department's approval shall be maintained by the closed-door medical cannabis pharmacy.

(f) The alternate location shall be secured and accessible only to authorized medical cannabis pharmacy employees.

(12) Upon request, a closed-door medical cannabis pharmacy shall provide any documentation required to be maintained in this rule to the department for review.

Notes

Utah Admin. Code R66-10-9

Adopted by Utah State Bulletin Number 2025-03, effective 1/23/2025 Amended by Utah State Bulletin Number 2025-06, effective 2/24/2025